HORIZONH2020FP7
Brigham Inc
- Country
- USUnited States
- Defence projects
- 0
- Projects, all programmes
- 23
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 3,651,606
- Active
- 2010 to 2026
Projects
23 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| GlioZEROAdvanced technologies for zeroing in on high-grade gliomas | HORIZON | 2026 | Associated partner | Not stated |
| Micro-InsulinPrototype Spiked Microcapsule based Oral Insulin Pill For Diabetes. | HORIZON | 2025 | Associated partner | EUR 0 |
| ReModel-OPIdentifying strategies to reduce osteoporosis-driven bone loss through the development of microphysiological bone remodeling-on-chip tools | HORIZON | 2025 | Associated partner | EUR 0 |
| PlateCAV-3DDelineating PLATElet-induced sex-specific responses in Calcific Aortic Valve disease using 3D-bioprinting and proteomics. | HORIZON | 2025 | Associated partner | EUR 0 |
| dAIbetesFederated virtual twins for privacy-preserving personalised outcome prediction of type 2 diabetes treatment | HORIZON | 2024 | Participant | EUR 476,393 |
| VoluFaTEVoluFaTE: Volumetric programming of cells to control the fate and function of engineered tissues | HORIZON | 2023 | Associated partner | EUR 0 |
| REPO4EUPrecision drug REPurpOsing For EUrope and the world | HORIZON | 2022 | Participant | EUR 766,707 |
| GLIORESOLVETraining the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment | HORIZON | 2022 | Associated partner | EUR 0 |
| BrainChip4MEDBrain-on-a-chip as a preclinical model tool for the screening of theranostic nanoformulations for neurodegenerative diseases | H2020 | 2022 | Partner | EUR 0 |
| CLOCKriskTargeting the circadian clock in personalized disease prevention | HORIZON | 2022 | Participant | EUR 456,174 |
| Th17 tissue metabMetabolic imprinting of Th17 cells in disease pathogenesis | HORIZON | 2022 | Associated partner | EUR 0 |
| MACROVALVEUnderstanding the role of macrophages in the structural degeneration of bioprosthetic heart valve leaflets | H2020 | 2022 | Partner | EUR 0 |
| neuronsXnetsNetwork Analysis in Neocortex during Passive and Active Learning | H2020 | 2021 | Partner | EUR 0 |
| DynChanDynamic regulation of paracellular channel gating | H2020 | 2021 | Partner | EUR 0 |
| PRINT-CHEMOTo develop 3D bioPRINTed osteoinductive constructs that deliver CHEMOtherapeutics within large bone defects that are surgically created when removing bone tumours. | H2020 | 2019 | Partner | EUR 0 |
| STOPFOPSaracatinib Trial tO Prevent FOP | H2020 | 2019 | Participant | EUR 1,875 |
| DANTEUse of novel techniques to identify pathogenic versus non-pathogenic TH17 cells in experimental autoimmune encephalomyelitis, a murine model of multiple sclerosis. | H2020 | 2016 | Partner | EUR 0 |
| HOXA9 degradomeDeciphering the machinery involved in stability of the transcription factor HOXA9. | H2020 | 2016 | Partner | EUR 0 |
| FORCEImaging the Force of Cancer | H2020 | 2016 | Participant | EUR 49,375 |
| EPISTOPLong-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – tuberous sclerosis complex | FP7 | 2013 | Participant | EUR 653,053 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.